WJCS  Vol.4 No.10 , October 2014
Comparison of Plegisol and Modified ST Thomas Hospital Cardioplegic Solution in the Development of Ventricular Fibrillation after Declamping of the Aorta
ABSTRACT
Ventricular fibrillation seen just after declamping of the aorta is an undesirable condition causing myocardial injury. To return to normal rhythm, often internal shocks are applied. But defibrillation itself can also contribute to myocardial injury. So prevention of fibrillation is more important than treatment. 236 patients undergoing coronary artery by-pass surgery were included in this retrospective clinical study. 144 of those patients were operated using modified St. Thomas’ Hospital cardioplegic solution, for stopping the heart. In the other 92 patients, plegisol cardioplegic solution was used. We compared the two groups for the development of ventricular fibrilation after declamping of the aorta. In the modified St. Thomas’ Hospital group, ventricular fibrillation after declamping of the aorta was seen less frequently, this being statistically significant (22.2% vs. 52.2%, p = 0.026). This study shows that the modified St.Thomas’ Hospital cardioplegic solution is preferred for avoiding ventricular fibrillation occuring just after declamping of the aorta.

Cite this paper
Aldemir, M. , Karatepe, C. , Bakı, E. , Çarşanba, G. and Tecer, E. (2014) Comparison of Plegisol and Modified ST Thomas Hospital Cardioplegic Solution in the Development of Ventricular Fibrillation after Declamping of the Aorta. World Journal of Cardiovascular Surgery, 4, 159-166. doi: 10.4236/wjcs.2014.410023.
References
[1]   Dahl, C.F., Ewy, G.A., Warner, E.D. and Thomas, E.D. (1974) Myocardial Necrosis from Direct Current Countershock. Circulation, 50, 956-961.
http://dx.doi.org/10.1161/01.CIR.50.5.956

[2]   Jynge, P. and Sellevold, O.F. (1987) Cardioplegia: Mechanisms of Protection Revisited. Annales Chirurgiae Et Gynaecologiae, 76, 22-29.

[3]   Almdahl, S.M., Damstuen, J., Eide, M., Molstad, P., Halvorsen, P. and Veel, T. (2013) Potassium-Induced Conversion of Ventricular Fibrillation after Aortic Declamping. Interactive CardioVasc Thoracic Surgery, 16, 143-150.
http://dx.doi.org/10.1093/icvts/ivs455

[4]   Mehlhorn, U., Davis, K.L., Burke, E.J., Adams, D.L., Laine, G.A. and Allen, S.J. (1995) Impact of Cardiopulmonary Bypass and Cardioplegic Arrest on Myocardial Lymphatic Function. American Journal of Physiology, 268, H178-H183.

[5]   Chambers, D.J. and Fallouh, H.B. (2010) Cardioplegia and Cardiac Surgery: Pharmacological Arrest and Cardioprotection during Global Ischemia and Reperfusion. Pharmacology & Therapeutics, 27, 41-52.
http://dx.doi.org/10.1016/j.pharmthera.2010.04.001

[6]   Tang, X.N. and Yenari, M.A. (2010) Hypothermia as a Cytoprotective Strategy in Ischemic Tissue Injury. Ageing Research Reviews, 9, 61-68.
http://dx.doi.org/10.1016/j.arr.2009.10.002

[7]   Sarusi, A., Rárosi, F., Szucs, M., Csík, N., Farkas, A.S., Papp, J.G., et al. (2014) Absolute Beat-to-Beat Variability and Instability Parameters of ECG Intervals: Biomarkers for Predicting Ischaemia-Induced Ventricular Fibrillation. British Journal of Pharmacology, 171, 1772-1782.
http://dx.doi.org/10.1111/bph.12579

[8]   Krukenkamp, I.B. and Levitsky, S. (1996) Physiological and Cellular Mechanisms of Myocardial Protection. The American Journal of Surgery, 172, 79-84.
http://dx.doi.org/10.1016/S0002-9610(96)00075-X

[9]   Hendry, P.J., Masters, R.G. and Haspect, A. (1994) Is There a Place for Cold Crystalloid Cardioplegia in the 1990s? Annals of Thoracic Surgery, 58, 1690-1694.
http://dx.doi.org/10.1016/0003-4975(94)91662-4

[10]   Careaga, G., Salazar, D., Téllez, S., Sánchez, O., Borrayo, G. and Argüero, R. (2001) Clinical Impact of Histidine-Ketoglutarate-Tryptophan (HTK) Cardioplegic Solution on the Perioperative Period in Open Heart Surgery Patients. Archives of Medical Research, 32, 296-299.
http://dx.doi.org/10.1016/S0188-4409(01)00296-X

[11]   Gebhard, M.M., Bretschneider, H.J., Gersing, E., Preusse, C.J., Schnabel, Ph.A. and Ulbricht, L.J. (1983) Calcium-Free Cardioplegia-Pro. European Heart Journal, 4, 151-160.

[12]   Shaffer, R.F., Baumgarten, C.M. and Damiano Jr., R.J. (1998) Prevention of Cellular Edema Directly Caused by Hypothermic Cardioplegia: Studies in Isolated Human and Rabbit Atrial Myocytes. The Journal of Thoracic and Cardiovascular Surgery, 115, 1189-1195.
http://dx.doi.org/10.1016/S0022-5223(98)70420-9

[13]   Stinner, B., Krohn, E., Gebhard, M.M. and Bretschneider, H.J. (1989) Intracellular Sodium Activity and Bretschneider’s Cardioplegia: Continuous Measurement by Ionselective Microelectrodes at Initial Equilibration. Basic Research in Cardiology, 84, 197-207.
http://dx.doi.org/10.1007/BF01907929

[14]   Allen, S.J. and Drake, R.E. (1997) Microvascular Fluid Exchange. In: Yaksh, T.L., Ed., Anesthesia: Biological Foundations, Lippincott-Raven Publ., Philadelphia, 1417-1430.

[15]   Praeger, P.I., Kay, R.H., Moggio, R., Somberg, E., Pooley, R., Sarabu, M., Sanshala, V., Kubal, K., Kumar, V. and Reed, G.E. (1988) Prevention of Ventricular Fibrillation after Aortic Declamping during Cardiac Surgery. Texas Heart Institute Journal, 15, 98-101.

[16]   Koller, M.L., Riccio, M.L. and Gilmour Jr., R.F. (2000) Effects of (K) on Electrical Restitution and Activation Dynamics during Ventricular Fibrillation. The American Journal of Physiology: Heart and Circulatory Physiology, 279, H2665-H2672.

[17]   Sellevold, O.F., Berg, E.M. and Levang, O.W. (1995) Procaine Is Effective for Minimizing Postischemic Ventricular Fibrillation in Cardiac Surgery. Anesthesia Analgesia, 81, 932-938.

[18]   Fujii, M. and Chambers, D.J. (2013) Cardioprotection with Esmolol Cardioplegia: Efficacy as a Blood-Based Solution. European Journal of Cardio-Thoracic Surgery, 43, 619-627.
http://dx.doi.org/10.1093/ejcts/ezs365

[19]   Yakaitis, R.W., Thomas, J.D. and Mahaffey, J.E. (1975) Influence of pH and Hypoxia on the Success of Defibrillation. Critical Care Medicine, 3, 139-142.
http://dx.doi.org/10.1097/00003246-197507000-00003

[20]   Srinivasan, A.K., Shackcloth, M.J., Grayson, A.D. and Fabri, B.M. (2003) Preoperative Beta-Blocker Therapy in Coronary Artery Bypass Surgery: A Propensity Score Analysis of Outcomes. Interactive Cardiovascular and Thoracic Surgery, 2, 495-500.
http://dx.doi.org/10.1016/S1569-9293(03)00132-4

[21]   Kocogullari, C.U., Emmiler, M., Ayva, E., Sasirtan, T., Eren, N. and Cekirdekci, A. (2008) Preoperative Prophylaxis Can Decrease Rates of Atrial Fibrillation in Open Heart Surgery: A Retrospective Study. Heart Surgery Forum, 11, E159-E163.
http://dx.doi.org/10.1532/HSF98.20081003

[22]   Andrews, T.C., Reimold, S.C., Berlin, J.A. and Antman, E.M. (1991) Prevention of Supraventricular Arrhythmias after Coronary Artery Bypass Surgery: A Meta-Analysis of Randomised Control Trials. Circulation, 84, III236-III244.

[23]   Grigore, A.M., Armory, D.W. and White, W.D. (1999) β-Blockade and Neurological Outcome in Cardiac Surgery. Anesthesia Analgesia, 88, 89.

 
 
Top